TVRD Tvardi Therapeutics, Inc.
Company Analysis
Latest News
🔴 Tvardi Therapeutics is trading 5.66% down in pre-market with no clear company-specific catalyst identified
Tvardi Therapeutics is trading at $1.00, down 5.66% in pre-market; no clear company-specific catalyst for the decline was identified. - The company’s latest...
🟢 Tvardi Therapeutics is trading 5.8% up in pre-market with no clear catalyst identified
Tvardi Therapeutics is trading 5.8% up in pre-market at $1.09, versus the $1.03 October 9 close; no clear catalyst has been identified. - The move follows a...
🔴 Tvardi Therapeutics is trading 5% down on October 9 with no clear company-specific catalyst identified
Tvardi Therapeutics is trading at $1.02, down 5.09%, with no clear company-specific catalyst identified during the October 9 session. - The latest listed...
🟢 Tvardi Therapeutics is trading 12.4% up in pre-market
Tvardi Therapeutics is trading 12.39% up at $1.21 in pre-market, with no clear catalyst identified. - The move follows several declining sessions; the October...
🔴 Tvardi Therapeutics is trading 5% down today as biotech falls 2.04%
Tvardi Therapeutics is trading at $1.04, down 5.00%, as broader market and biotech weakness may be weighing on shares. - No October 8 company-specific...
🟢 Tvardi Therapeutics is trading 6.5% up in after-hours trading
Tvardi Therapeutics is trading at $1.15, up 6.48% in after-hours trading; no clear catalyst was identified. - The stock closed at $1.08 on October 6, after...
🔴 Tvardi Therapeutics is trading 5% down amid broader biotechnology weakness
Tvardi Therapeutics is trading 5.26% lower at $1.08, with biotechnology-sector weakness the likeliest explanation; no direct cause for the individual move is...
🟢 Tvardi Therapeutics is trading 6.1% up in pre-market with no clear catalyst identified
Tvardi Therapeutics is trading 6.14% higher at $1.21 in pre-market; no clear company-specific catalyst was identified for the October 6, 2026 move. - The...
🟢 Tvardi Therapeutics is trading 6.1% up in pre-market with no clear company-specific catalyst identified
Tvardi Therapeutics is trading at $1.22, up 6.1%, in pre-market on October 5 versus the supplied previous close of $1.15; no clear company-specific...
🔴 Tvardi Therapeutics is trading 5.7% down — no clear company-specific catalyst identified
Tvardi Therapeutics is trading 5.7% lower at $1.17, with no clear company-specific announcement identified to explain the October 2 move. - The broader market...
🟢 Tvardi Therapeutics is trading 10.5% up in pre-market — catalyst remains unclear
Tvardi Therapeutics is trading at $1.38, up 10.51%, with the October 1 pre-market gain’s cause unclear. - No clear company-specific announcement or catalyst...
🔴 Tvardi Therapeutics is trading 9.7% down in pre-market with no clear company-specific catalyst
Tvardi Therapeutics is trading 9.72% down at $1.13, versus the September 30 close of $1.25; no clear company-specific catalyst was identified for the...
🔴 Tvardi Therapeutics is trading 9.6% down in after-hours trading
Tvardi Therapeutics is trading at $1.13, down 9.60% in after-hours trading, with no clear company-specific catalyst identified. - The regular-session close...
🔴 Tvardi Therapeutics is trading 5% down with no clear company-specific catalyst identified
Tvardi Therapeutics is trading at $1.22 (-5.08%) during the September 30, 2026 session, with no clear company-specific catalyst identified. - The latest...
🟢 Tvardi Therapeutics is trading 5.7% up in pre-market
Tvardi Therapeutics is trading 5.70% higher at $1.35 in pre-market on September 30, 2026; the reason for the move remains unclear. - Available reporting and...
🟢 Tvardi Therapeutics is trading 5% up as catalyst remains unclear
Tvardi Therapeutics is trading 5.26% up at $1.40, with the cause of the September 29, 2026 move unclear. - The latest company news located was September 24...
🔴 Tvardi Therapeutics is trading 6% down in pre-market with no clear catalyst identified
Tvardi Therapeutics is trading at $1.25, down 6.02% in pre-market; available evidence does not establish a cause for the September 29 decline. - No new...
🟢 Tvardi Therapeutics is trading 5% up
Tvardi Therapeutics is trading 5.08% up at $1.33 on September 28, 2026, with no specific catalyst identified for the session’s gain. - Supplied price history...
🔴 Tvardi Therapeutics is trading 5% down amid broad market weakness
Tvardi Therapeutics is trading at $1.21, with a -5.12% change during the September 28 session, alongside a weaker market. - The supplied context shows the S&P...
🟢 Tvardi Therapeutics is trading 10% up in pre-market with no confirmed catalyst
Tvardi Therapeutics is trading 10.21% higher at $1.40, with no confirmed catalyst for September 28 identified. - The price is versus the September 25 close of...